Unresectable Rectal Adenocarcinoma

specific

A rectal adenocarcinoma that is not amenable to surgical resection.

39

Centers

34

Active Trials

Cancer Funding

Top Centers for Unresectable Rectal Adenocarcinoma(39)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
High-Volume Research Center
73.2
2
NCI Comprehensive
Active Research Program
54.2
3
NCI Comprehensive
Active Research Program
54.2
4
NCI Comprehensive
Active Research Program
54.2
5
NCI Comprehensive
Active Research Program
54.2
6
NCI Comprehensive
Active Research Program
54.2
7
NCI Comprehensive
Active Research Program
54.2
8
NCI Comprehensive
Active Research Program
54.2
9
NCI Comprehensive
Active Research Program
54.2
10
NCI Comprehensive
Active Research Program
54.2
11
NCI Comprehensive
Active Research Program
54.2
12
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
54.2
13
NCI Comprehensive
Active Research Program
54.2
14
NCI Comprehensive
Active Research Program
54.2
15
NCI Comprehensive
Active Research Program
54.2
16
NCI Comprehensive
Active Research Program
54.2
17
NCI Comprehensive
Active Research Program
54.2
18
NCI Clinical
Active Research Program
54.2
19
NCI Comprehensive
Active Research Program
54.2
20
NCI Comprehensive
Active Research Program
54.2
21
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
54.2
22
NCI Comprehensive
Active Research Program
54.2
23
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
54.2
24
NCI Clinical
Active Research Program
54.2
25
Active Research Program
54.2
2654.2
27
Active Research Program
54.2
28
Active Research Program
54.2
29
Active Research Program
54.2
30
Active Research Program
54.2
3154.2
32
Active Research Program
54.2
33
Active Research Program
54.2
34
NCI Comprehensive
32.2
35
NCI Comprehensive
32.2
36
NCI Comprehensive
32.2
3732.2
38
NCI Comprehensive
32.2
39
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
32.2

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →